NCT06564246View on ClinicalTrials.gov

Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG

Vonoprazan 20 mg versus Pantoprazole 40 mg

Patients divided into two arms First Arm administered vonoprazan Second arm administered pantoprazole

Trial Locations (1)

Unknown

RECRUITING

Theodore Billiharz Institute for Researchs, Giza

All Listed Sponsors
lead

Tanta University

OTHER